Psychiatry · Brooklyn, NY
NPI
1548250475
Since 2005
Specialty
Psychiatry
Code 2084P0800X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
920 E 17th St
Brooklyn, NY, 11230
Phone (171) 825-2772
Groups this clinician bills Medicare through
Medicare paid, 2024
$294K
3,741 services
Medicare patients, 2024
529
Average age 76
Drug cost, 2024
$2.0M
8,356 prescriptions
Company payments, 2025
$29.98
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Inna Markhasina was code 99213 (office e&m - established), 2,743 times for 487 patients. In total Inna Markhasina billed 3,741 services in 13 codes, and Medicare paid $294K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-05-31.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 2,743 | 487 | $73.96 | $203K |
| 99214 Office E&M - Established | Office | 472 | 299 | $104.78 | $49K |
| 90836 Psychotherapy - Nongroup | Office | 205 | 68 | $75.34 | $15K |
| 90833 Psychotherapy - Nongroup | Office | 194 | 122 | $55.95 | $11K |
| 90792 Psychotherapy - Nongroup | Office | 72 | 72 | $153.41 | $11K |
| 90846 Psychotherapy - Nongroup | Office | 30 | 21 | $77.15 | $2,314 |
| 99212 Office E&M - Established | Office | 15 | 12 | $50.37 | $756 |
By year: 2022 $291K for 2,774 services; 2023 $332K for 3,158 services; 2024 $294K for 3,741 services.
Medicare prescription drug claims, 2024
In 2024, the drug Inna Markhasina prescribed most often to Medicare patients was Zolpidem Tartrate, with 1,150 prescriptions and refills. In total Inna Markhasina wrote 8,356 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Zolpidem Tartrate Generic | 1,150 | 1,150 | 217 | $2,891 |
| Namzaric Memantine Hcl/Donepezil Hcl | 672 | 672 | 91 | $373K |
| Escitalopram Oxalate Generic | 561 | 572 | 89 | $2,063 |
| Trintellix Vortioxetine Hydrobromide | 552 | 552 | 67 | $254K |
| Rivastigmine Generic | 472 | 472 | 83 | $36K |
| Latuda Lurasidone Hcl | 447 | 447 | 69 | $597K |
| Trazodone Hcl Generic | 398 | 406 | 61 | $1,101 |
| Lorazepam Generic | 385 | 385 | 80 | $946 |
| Mirtazapine Generic | 330 | 331 | 46 | $2,348 |
| Clonazepam Generic | 311 | 311 | 60 | $1,195 |
| Alprazolam Generic | 264 | 264 | 55 | $689 |
| Quetiapine Fumarate Generic | 250 | 251 | 39 | $1,238 |
| Sertraline Hcl Generic | 223 | 224 | 27 | $358 |
| Memantine Hcl Er Memantine Hcl | 162 | 163 | 34 | $9,435 |
| Lurasidone Hcl Generic | 158 | 159 | 27 | $32K |
Brand drugs: 2,526 claims; generic drugs: 5,830 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Inna Markhasina $29.98 ($29.98 in general payments such as food, travel and fees) from 1 company. The largest payer was 180 Medical, Inc. with $29.98.
| Company | Payments | Amount |
|---|---|---|
| 180 Medical, Inc. | 1 | $29.98 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.